"10.1371_journal.pone.0023780","plos one","2011-08-17T00:00:00Z","Claudius Mueller; Kirsten H Edmiston; Calvin Carpenter; Eoin Gaffney; Ciara Ryan; Ronan Ward; Susan White; Lorenzo Memeo; Cristina Colarossi; Emanuel F Petricoin; Lance A Liotta; Virginia Espina","Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, United States of America; Cancer Translational Research Center, Inova Fairfax Hospital, Inova Health System, Falls Church, Virginia, United States of America; Center for Biodefense and Infectious Disease, George Mason University, Manassas, Virginia, United States of America; St. Jamess Hospital, Dublin, Ireland; Pathology Unit, Mediterranean Institute of Oncology, Catania, Italy","Conceived and designed the experiments: CM EG LM LAL VE. Performed the experiments: CM EG CR RW SW LM C. Colarossi LAL VE. Analyzed the data: CM EG CR LM LAL VE. Contributed reagents/materials/analysis tools: CM KHE C. Colarossi LM C. Carpenter LAL VE. Wrote the paper: CM EFP LAL VE.","The authors have read the journals policy and have the following conflicts: The technology discussed in this manuscript has been developed under a National Institutes of Health (NIH) grant to LAL (R21CA125698-01A1) from the National Cancer Institute program “Innovations in cancer sample preparation”. Aspects of this technology, owned by George Mason University, have been submitted as a patent application on January 25, 2011 under the title of “Improved One-Step Cell and Tissue Preservative for Morphologic and Molecular Analysis” (PCT/US11/22463), and some of the authors (CM, LAL, EFP, VE) are co-inventors. This application is licensed by George Mason University to Theranostics Health, Inc., which is currently developing a product. LAL, EFP and VE are stock holders of Theranostics Health, Inc. The authors adhere to the NIH and PLoS ONE policies on sharing data and materials.","2011","08","Claudius Mueller","CM",12,TRUE,5,7,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
